Nuclear receptors, bile-acid detoxification, and cholestasis

被引：29

作者：

Chen, JZ ^{[1
]}

Raymond, K ^{[1
]}

机构：

[1] La Trobe Univ, Fac Sci Technol & Engn, Sch Pharm & Appl Sci, Bendigo, Vic 3550, Australia

来源：

LANCET | 2006年 / 367卷 / 9509期

关键词：

D O I：

10.1016/S0140-6736(06)68156-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：454 / 456

页数：3

共 20 条

[1]

BACHS L, 1989, LANCET, V1, P574

[2] Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats [J].

Chen, JH ;

Robertson, G ;

Field, J ;

Liddle, C ;

Farrell, GC .

HEPATOLOGY, 1998, 28 (03) :624-630

[3] Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: Relevance to drug metabolism in experimental cholestasis [J].

Chen, JZ ;

Farrell, GC .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1996, 11 (09) :870-877

[4]

Chitturi S, 2001, Semin Gastrointest Dis, V12, P113

[5] The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp [J].

Denson, LA ;

Sturm, E ;

Echevarria, W ;

Zimmerman, TL ;

Makishima, M ;

Mangelsdorf, DJ ;

Karpen, SJ .

GASTROENTEROLOGY, 2001, 121 (01) :140-147

[6] No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis [J].

Dilger, K ;

Denk, A ;

Heeg, MHJ ;

Beuers, U .

HEPATOLOGY, 2005, 41 (03) :595-602

[7] Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis [J].

Fiorucci, S ;

Clerici, C ;

Antonelli, E ;

Orlandi, S ;

Goodwin, B ;

Sadeghpour, BM ;

Sabatino, G ;

Russo, G ;

Castellani, D ;

Willson, TM ;

Pruzanski, M ;

Pellicciari, R ;

Morelli, A .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (02) :604-612

[8] Regulation of CYP3A4 by the bile acid receptor FXR:: evidence for functional binding sites in the CYP3A4 gene [J].

Gnerre, C ;

Blättler, S ;

Kaufmann, MR ;

Looser, R ;

Meyer, UA .

PHARMACOGENETICS, 2004, 14 (10) :635-645

[9] Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis [J].

Goulis, J ;

Leandro, G ;

Burroughs, AK .

LANCET, 1999, 354 (9184) :1053-1060

[10] Farnesoid X receptor activates transcription of the phospholipid pump MDR3 [J].

Huang, L ;

Zhao, A ;

Lew, JL ;

Zhang, T ;

Hrywna, Y ;

Thompson, JR ;

de Pedro, N ;

Royo, I ;

Blevins, RA ;

Peláez, F ;

Wright, SD ;

Cui, JS .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (51) :51085-51090

← 1 2 →